Steven J. Coats

1.9k total citations · 1 hit paper
64 papers, 1.5k citations indexed

About

Steven J. Coats is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Steven J. Coats has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 27 papers in Organic Chemistry and 26 papers in Molecular Biology. Recurrent topics in Steven J. Coats's work include HIV/AIDS drug development and treatment (38 papers), Hepatitis C virus research (22 papers) and Biochemical and Molecular Research (16 papers). Steven J. Coats is often cited by papers focused on HIV/AIDS drug development and treatment (38 papers), Hepatitis C virus research (22 papers) and Biochemical and Molecular Research (16 papers). Steven J. Coats collaborates with scholars based in United States, France and Egypt. Steven J. Coats's co-authors include Raymond F. Schinazi, Franck Amblard, Ugo Pradère, Ethel C. Garnier‐Amblard, Harry H. Wasserman, Dennis J. Hlasta, Tamara R. McBrayer, Longhu Zhou, Hongwang Zhang and Tony Whitaker and has published in prestigious journals such as Chemical Reviews, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Steven J. Coats

64 papers receiving 1.4k citations

Hit Papers

Synthesis of Nucleoside P... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven J. Coats United States 19 791 586 477 240 239 64 1.5k
Longhu Zhou United States 21 609 0.8× 279 0.5× 253 0.5× 152 0.6× 155 0.6× 55 986
Bruce S. Ross United States 17 351 0.4× 762 1.3× 644 1.4× 551 2.3× 452 1.9× 42 1.6k
Murray D. Bailey Canada 15 609 0.8× 321 0.5× 273 0.6× 465 1.9× 230 1.0× 25 1.2k
Marc‐André Poupart Canada 18 391 0.5× 520 0.9× 346 0.7× 550 2.3× 303 1.3× 29 1.3k
James Gillard Canada 19 469 0.6× 314 0.5× 273 0.6× 330 1.4× 177 0.7× 30 975
John F. Kadow United States 30 1.0k 1.3× 689 1.2× 605 1.3× 129 0.5× 173 0.7× 110 2.2k
Kazuhiro Haraguchi Japan 25 859 1.1× 1.0k 1.8× 575 1.2× 40 0.2× 243 1.0× 120 1.9k
Ugo Pradère France 11 447 0.6× 389 0.7× 294 0.6× 42 0.2× 113 0.5× 13 767
Christophe Mathé France 16 424 0.5× 578 1.0× 507 1.1× 52 0.2× 203 0.8× 71 1.1k
Siegfried Goldmann Germany 18 734 0.9× 489 0.8× 219 0.5× 511 2.1× 609 2.5× 33 1.7k

Countries citing papers authored by Steven J. Coats

Since Specialization
Citations

This map shows the geographic impact of Steven J. Coats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Coats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Coats more than expected).

Fields of papers citing papers by Steven J. Coats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Coats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Coats. The network helps show where Steven J. Coats may publish in the future.

Co-authorship network of co-authors of Steven J. Coats

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Coats. A scholar is included among the top collaborators of Steven J. Coats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Coats. Steven J. Coats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bassit, Leda, Christina Gavegnano, Tamara R. McBrayer, et al.. (2017). Synthesis and antiviral evaluation of 2′,2′,3′,3′-tetrafluoro nucleoside analogs. Tetrahedron Letters. 58(7). 642–644. 11 indexed citations
2.
Zhou, Shaoman, Peng Liu, Longhu Zhou, et al.. (2017). 2′-Chloro,2′-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture. Journal of Medicinal Chemistry. 60(13). 5424–5437. 19 indexed citations
3.
Coats, Steven J., et al.. (2017). Synthesis of (2S)-2-Chloro-2-fluororibolactone via Stereoselective Electrophilic Fluorination. The Journal of Organic Chemistry. 82(24). 13171–13178. 6 indexed citations
4.
Schinazi, Raymond F., et al.. (2015). Synthesis and antiviral evaluation of 2′,3′-dideoxy-2′,3′-difluoro-D-arabinofuranosyl 2,6-disubstituted purine nucleosides. Heterocyclic Communications. 21(5). 315–327. 5 indexed citations
5.
Tao, Sijia, Franck Amblard, Richard A. Stanton, et al.. (2015). Design, synthesis and evaluation of novel anti-HCV molecules that deliver intracellularly three highly potent NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3711–3715. 2 indexed citations
6.
Cho, Jong Hyun, Mervi Detorio, Leda Bassit, et al.. (2014). Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs. Bioorganic & Medicinal Chemistry. 22(23). 6665–6671. 3 indexed citations
7.
Nettles, James H., Richard A. Stanton, Franck Amblard, et al.. (2014). Asymmetric Binding to NS5A by Daclatasvir (BMS-790052) and Analogs Suggests Two Novel Modes of HCV Inhibition. Journal of Medicinal Chemistry. 57(23). 10031–10043. 35 indexed citations
8.
Zhou, Longhu, Franck Amblard, Hongwang Zhang, et al.. (2013). Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(11). 3385–3388. 7 indexed citations
9.
Amblard, Franck, Hongwang Zhang, Longhu Zhou, et al.. (2013). Synthesis and evaluation of non-dimeric HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 2031–2034. 21 indexed citations
10.
Coats, Steven J., Ethel C. Garnier‐Amblard, Franck Amblard, et al.. (2013). Chutes and ladders in hepatitis C nucleoside drug development. Antiviral Research. 102. 119–147. 59 indexed citations
12.
Shi, Junxing, Longhu Zhou, Franck Amblard, et al.. (2012). Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(10). 3488–3491. 19 indexed citations
13.
Cho, Jong Hyun, Franck Amblard, Steven J. Coats, & Raymond F. Schinazi. (2011). Efficient synthesis of nucleoside aryloxy phosphoramidate prodrugs utilizing benzyloxycarbonyl protection. Tetrahedron. 67(30). 5487–5493. 16 indexed citations
14.
Shi, Junxing, Longhu Zhou, Hongwang Zhang, et al.. (2011). Synthesis and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5′-triphosphates. Bioorganic & Medicinal Chemistry Letters. 21(23). 7094–7098. 16 indexed citations
15.
Schinazi, Raymond F., et al.. (2010). Advances in nucleoside monophosphate prodrugs as anti-HCV agents. Antiviral Therapy. 15(7). 935–950. 41 indexed citations
16.
Zhang, Hongwang, Steven J. Coats, Franck Amblard, et al.. (2009). Synthesis and evaluation of 3′-azido-2′,3′-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. Bioorganic & Medicinal Chemistry Letters. 20(1). 60–64. 11 indexed citations
17.
Lisko, Joseph G., Jeffrey M. Palmer, John R. Mabus, et al.. (2009). Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19(10). 2661–2663. 10 indexed citations
18.
Wasserman, Harry H., et al.. (2008). The dimer of phenylpropiolyl chloride. Tetrahedron Letters. 49(13). 2049–2051. 2 indexed citations
19.
Coats, Steven J., Mark J. Schulz, John R. Carson, et al.. (2004). Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists. Bioorganic & Medicinal Chemistry Letters. 14(22). 5493–5498. 20 indexed citations
20.
Wasserman, Harry H., et al.. (1995). Cyclopentenones and cyclopentanones from the reactions of vinyl vicinal tricarbonyls with carbon nucleophiles. Tetrahedron Letters. 36(37). 6785–6788. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026